Immunological Work Up

  • G. Burg
  • T. Rehle
Conference paper

Abstract

According to Macher [65] 14% of dermatoses are directly pathogenetically related to immune mechanisms. In an additional 28% the immune system plays a role in the pathologic process.

Keywords

Lymphoma Psoriasis Dermatitis Sarcoidosis Dermatol 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Berger CL, Warburton D, Raafat I, LoGerlo P, Edelson RL (1979) Cutaneous T-cell lymphoma: Neoplasm of T cells with helper activity. Blood 53:642–651PubMedGoogle Scholar
  2. 2.
    Bernengo MG, Capella G, Mascoli I, Zina G (1977) Active rosette test in cutaneous lymphoproliferative disorders. Dermatologica 154:342–349PubMedCrossRefGoogle Scholar
  3. 3.
    Bice DE, Heins G, Solvaggio I (1976) Lymphocyte stimulation and plasma inhibition in patients with malignant neoplasms. Int Arch Allergy Appl Immunol 50:613–624PubMedCrossRefGoogle Scholar
  4. 4.
    Bickhardt R, Kunze I (1974) Beiträge zur immunologischen Reaktionsbereitschaft beim malignen Melanom. Z Hautkr 49/8:315–333PubMedGoogle Scholar
  5. 5.
    Blaylock WK, Clendenning WE, Carbone PP, Scott EI van (1966) Normal immunologic reactivity in patients with the lymphoma mycosis fungoides. Cancer 19:233–276PubMedCrossRefGoogle Scholar
  6. 6.
    Bleumink E, Nater JP (1974) DNCB reactivity in patients with skin carcinoma. Dermatologica 148:44–46PubMedGoogle Scholar
  7. 7.
    Bleumink E, Nater JP, Schraffordt H, The TA (1974) A standard method for DNCB sensitisation testing in patients with neoplasms. Cancer 33:911–915PubMedCrossRefGoogle Scholar
  8. 8.
    Bos JD, Hamerlinck F, Cormane R (1980) Immunoglobulin-bearing lymphoid cells in primary syphilis. Br J Vener Dis 56:69–73PubMedGoogle Scholar
  9. 9.
    Bos JD, Hamerlinck F, Cormane RH (1980) T lymphoid cells in primary syphilis. Br J Vener Dis 56:74–76PubMedGoogle Scholar
  10. 10.
    Braathen LR, Førre Ø, Natvig JB (1979) Dermatitis herpetiformis: lymphocytes, immunoglobulins and complement factors in peripheral blood. Acta Derm Venereol (Stockh) 59:39–44Google Scholar
  11. 11.
    Brass B, Theml H, Backmund H, Lob G, Seifert J, Brendel W, Speisberg F (1973) Drainage des Ductus thoracicus beim Menschen. Med Klin 68:1399PubMedGoogle Scholar
  12. 12.
    Braylan R, Variakojis D, Yachnin S (1975) The Sézary syndrome lymphoid cell: abnormal surface properties and mitogen responsiveness. Br J Haematol 31:553–564PubMedCrossRefGoogle Scholar
  13. 13.
    Bremer K, Fliedner TM (1973) Neuere Gesichtspunkte zur Kinetik von Lymphozytenpopulationen. In: Stacher A (ed) Leukämien und maligne Lymphome. Urban & Schwarzenberg, Munich Berlin Vienna, pp 202–211Google Scholar
  14. 14.
    Buckley RH (1976) The functions and measurement of human B- and T-Lymphocytes. J Invest Dermatol 67:381–390PubMedCrossRefGoogle Scholar
  15. 15.
    Burg G, Braun-Falco O (1977) 1-Chlor-2, 4-dinitrobenzol (DNCB)-Salbe zur Sensibilisierung, Testung und Behandlung von Patienten mit malignem Melanom. Dtsch Med Wochenschr 102:210–211PubMedGoogle Scholar
  16. 16.
    Burg G, Braun-Falco O (to be published) Cutaneous lymphomas, pseudolymphomas, and related disorders. Springer, Berlin Heidelberg New YorkGoogle Scholar
  17. 17.
    Burg G, Rodt H, Grosse-Wilde H, Braim-Falco O (1978) Surface markers and mitogen response of cells harvested from cutaneous infiltrates in mycosis fungoides and Sézary’s syndrome. J Invest Dermatol 70:257–259PubMedCrossRefGoogle Scholar
  18. 18.
    Byrom NP, Timlin DM (1979) Immune status in atopic eczema: a survey. Br J Dermatol 100:491–498PubMedCrossRefGoogle Scholar
  19. 19.
    Carosella ED, Mochanko K, Braun M (1974) Rosette-forming T cells in human peripheral blood at different ages. Cell Immunol 12:323–325PubMedCrossRefGoogle Scholar
  20. 20.
    Carpeto FJ, Winkelmann RR (1975) Peripheral blood lymphocyte distribution in scleroderma. Dermatologica 151:228–235CrossRefGoogle Scholar
  21. 21.
    Catalona WI, Chretien PB (1973) Abnormalities of quantitative dinitrochlorobenzene sensitization in cancer patients: Correlation with tumor stage and histology. Cancer 31:353–356PubMedCrossRefGoogle Scholar
  22. 22.
    Catalona WI, Sample WF, Chretien PB (1973) Lymphocyte reactivity in cancer patients: Correlation with tumor histology and clinical stage. Cancer 31:65–71PubMedCrossRefGoogle Scholar
  23. 23.
    Chakravorty RC, Curutchet HP, Copolla FS, Park CM, Blaylock WK, Lawrence W (1973) The delayed hypersensitivity reaction in cancer patients: Observations on sensitization by DNCB. Surgery 73:730–735PubMedGoogle Scholar
  24. 24.
    Chretien JH, Esswein JG, Garagus i VF (1978) Decreased T cell levels in patients with warts. Arch Dermatol 114:213–215PubMedCrossRefGoogle Scholar
  25. 25.
    Clendenning WE, Scott EI van (1965) Skin autografts and homografts in patients with the lymphoma mycosis fungoides. Cancer Res 25:1844–1853Google Scholar
  26. 26.
    Clot I, Guilhou II, Meynadier I, Paradis B, Andary M (1978) Immunological aspects of psoriasis. Br J Dermatol 99:25–30PubMedCrossRefGoogle Scholar
  27. 27.
    Cohnen G, Augener W, Reuter A, Brittinger G (1975) Peripheral blood T- and B-lymphocytes in men in different age groups. Z Immunitätsforsch Immunobiol 149:463–468Google Scholar
  28. 28.
    Cooperrider PA, Roenigk HH (1978) Selective immunological evaluation of mycosis fungoides. Arch Dermatol 114:207–212PubMedCrossRefGoogle Scholar
  29. 29.
    Cormane RH, Husz S, Hamerlinck F (1974) Immunoglobulin — and complement-bearing lymphocytes in allergic contact dermatitis and atopic dermatitis (eczema). Br J Dermatol 90:597–605PubMedCrossRefGoogle Scholar
  30. 30.
    Cormane RH, Hunyadi J, Hamerlinck F (1977) Immungenetische Aspekte der Pathogenese der Psoriasis. Dermatol Monatsschr 163:885–899PubMedGoogle Scholar
  31. 31.
    Depaoli M (1953) Über die toxische Reaktion und die Sensibilisierung gegen 2,4-Dinitrochlorbenzol bei Psoriasiskranken. Hautarzt 4:319–320PubMedGoogle Scholar
  32. 32.
    Du Vivier A, Harper RA, Vonderheid E, Scott EI van (1978) Lymphocyte transformation in patients with staged mycosis fungoides and Sézary Syndrom. Cancer 42:209–213PubMedCrossRefGoogle Scholar
  33. 33.
    Dwyer IM, Bullock WE, Fields IP (1973) Disturbance of the blood T: B lymphocyte ratio in lepromatous leprosy. N Engl J Med 288:1036–1039PubMedCrossRefGoogle Scholar
  34. 34.
    Elliott ST, Hanifin IM (1979) Delayed cutaneous hypersensitivity and lymphocyte transformation. Arch Dermatol 115:36–39PubMedCrossRefGoogle Scholar
  35. 35.
    Elliott ST, Hanifin IM (1979) Lymphocyte response to phytohemagglutinin in atopic dermatitis. Arch Dermatol 115:1424–1426PubMedCrossRefGoogle Scholar
  36. 36.
    Fass L, Ziegler IL, Herberman RB, Kiryabwire IWM (1970) Cutaneous hypersensitivity reactions to autologous extracts of malignant melanoma cells. Lancet 1:116–118PubMedCrossRefGoogle Scholar
  37. 37.
    Fjelde A, Kopecka B (1967) Cell transformation and mitogenic effects in blood leucocyte cultures of atopic dermatitis patients. Acta Derm Venereol (Stockh) 47:168–176Google Scholar
  38. 38.
    Fraser DG, Bull IG, Dunphy IE (1971) Malignant melanoma and coexisting malignant neoplasms. Am J Surg 122:169–174PubMedCrossRefGoogle Scholar
  39. 39.
    Gianetti A, Silverio AD, Castellazzi AM, Maccario R (1978) Evidence for defective T cell function in patients with alopecia areata. Br J Dermatol 98:361CrossRefGoogle Scholar
  40. 40.
    Glinski W, Obalek S, Langner A, Jablonska S, Haftek M (1978) Defective function of T lymphocytes in psoriasis. J Invest Dermatol 70:105–110PubMedCrossRefGoogle Scholar
  41. 41.
    Golub SH, O’Connell TX, Morton DL (1974) Correlation of in vivo and in vitro assays of immunocompetence in cancer patients. Cancer Res 34:1833–1837PubMedGoogle Scholar
  42. 42.
    Grond K, Tilz GP, Kresbach H, Kerl H (1975) Regression multipler Hautmetastasen eines Melanomalignoms unter Immuntherapie. Z Hautkr 50/6:233–244Google Scholar
  43. 43.
    Guilhou II, Clot I, Robinet-Levy M, Meynadier I (1977) IgE et immunité cellulaire dans les hématodermies. Ann Dermatol Venereol 104:533–537PubMedGoogle Scholar
  44. 44.
    Harper RA, Tarn DW, Vorderheid ER, Urbach F (1979) Normal T lymphocyte function in psoriatic patients undergoing methoxsalen photochemotherapy. J Invest Dermatol 72:323–325PubMedCrossRefGoogle Scholar
  45. 45.
    Haslinger I (1979) Immunstatus bei kutanen Lymphomen. Medical dissertation, University of MunichGoogle Scholar
  46. 46.
    Hersey P, Edwards A, Honeyman M, McCarthy WH (1979) Low natural killer-cell activity in familial melanoma patients and their relatives. Br J Cancer 40:113–122PubMedCrossRefGoogle Scholar
  47. 47.
    Howard J (1972) The life-span and recirculation of marrow-derived small lymphocytes from the rat thoracic duct. J Exp Med 135:185PubMedCrossRefGoogle Scholar
  48. 48.
    Hunyadi I, Dobozy A, Husz S, Kenderessy AS, Szegedi G, Simon N (1979) Suppressor activity of peripheral blood mononuclear cells in patients with chronic discoid lupus erythematosus Arch Dermatol Res 265:317–320PubMedCrossRefGoogle Scholar
  49. 49.
    Iversen IG (1969) Phytohemagglutinin response of recirculating and non-recirculating rat lymphocytes. Exp Cell Res 50:219CrossRefGoogle Scholar
  50. 50.
    Jablonska S, Orth G, Jarzabek-Chorzelska M, Rzesa G, Obalek S, Glinski W, Favre M, Croissant O (1979) Epidermodysplasia verruciformis versus disseminated Verrucae planae: Is epidermodysplasia verruciformis a generalized infection with wart virus? J Invest Dermatol 72:114–119PubMedCrossRefGoogle Scholar
  51. 51.
    Jablonska S, Beutner EH, Binder WL, Jarzabek-Chorzelska M, Rzesa G, Chowanicz O (1979) Immunopathology of psoriasis. Arch Dermatol Res 264:65–71PubMedCrossRefGoogle Scholar
  52. 52.
    Kaaman T, Petrini B, Wassermann I (1979) In vivo and in vitro immune responses to trichophytin in dermatophytosis. Acta Derm Venereol (Stockh) 59:229–233Google Scholar
  53. 53.
    Kantor FS, Dwyer JM, Mangi RJ (1976) Sarcoid. J Invest Dermatol 67:470–476PubMedCrossRefGoogle Scholar
  54. 54.
    King GW, Grozea PC, Eyre HI, Le Buglio AF (1979) Neoantigen response in patients successfully treated for lymphoma. Ann Intern Med 90:892–895PubMedGoogle Scholar
  55. 55.
    Kinoshita M, Kawada A (1976) Cell-mediated immunity in mycosis fungoides. J Dermatol (Tokyo) 3:97–102Google Scholar
  56. 56.
    Klein R, Krüger GRF, Sesterhenn K (1978) T-Lymphozyten im peripheren Blut. Eine Untersuchung an 113 Patienten mit malignen Melanomen. Z Hautkr 53:62–66PubMedGoogle Scholar
  57. 57.
    Kövary PM, Niedorf H, Sommer G, Breu H, Kamanabroo P, Büchner T, Macher E (1977) Paraproteinaemia in Sézary Syndrom. Dermatologica 154:138–146PubMedCrossRefGoogle Scholar
  58. 58.
    Kokoschka EM, Micksche M (1977) Immunologie und Therapie des malignen Melanoms. Wien Klin Wochenschr 89:612–622PubMedGoogle Scholar
  59. 59.
    Kubba R, Bailin L, Roenigk H (1980) Immunologic evaluation in mycosis fungoides. Arch Dermatol 116:178–181PubMedCrossRefGoogle Scholar
  60. 60.
    Langner A, Pawinska-Proniewska M, Glinski W, Maj S (1971) Cytotoxic factors in inhibition of lymphocyte transformation in lymphomata. Br J Dermatol 85:7–13CrossRefGoogle Scholar
  61. 61.
    Langner A, Glinski W, Pawinska M, Obalek S (1975) Lymphocyte transformation in mycosis fungoides. Arch Dermatol Res 251:249–257CrossRefGoogle Scholar
  62. 62.
    Liebe V von, Burg G (1977) Lymphozytentransformationstest bei kutanen Lymphomen. Hautarzt [Suppl] 2:200–203Google Scholar
  63. 63.
    Livden JK, Matre R, Haugen A, Bjerke IL, Bang G, Wesenberg F (1979) A study of Sézary cells in peripheral blood and skin lesions. Acta Derm Venereol (Stockh) 59:70–73Google Scholar
  64. 64.
    Lutzner M, Edelson R, Schein P, Green I, Kirkpatrick C, Ahmed A (1975) Cutaneous T-cell lymphomas: The Sézary syndrome, mycosis fungoides, and related disorders. Ann Intern Med 83:534–552PubMedGoogle Scholar
  65. 65.
    Macher E (1977) Immunologie. Hautarzt [Suppl 3] 28:2–5Google Scholar
  66. 66.
    MacKie R, Sless FR, Cochran R. Sousa M de (1976) Lymphocyte abnormalities in mycosis fungoides. Br J Dermatol 94:173–178PubMedCrossRefGoogle Scholar
  67. 67.
    McGeady SJ, Buckley RH (1975) Depression of cell-mediated immunity in atopic dermatitis. J Allergy Clin Immunol 56:393PubMedCrossRefGoogle Scholar
  68. 68.
    Meneghini CL, Angelini G, Bonifazi E (1975) Immunity in tumours of the skin. Studies on cell-mediated immune reactions. Arch Dermatol Res 252:203–209CrossRefGoogle Scholar
  69. 69.
    Muchmore AV, Blaese RM, Altman LC (1978) Lack of effector cell function in chronic lymphocytic leukemia, a B-cell malignancy, and the Sézary syndrome, a T cell malignancy. Clin Immunol Immunopathol 10:306–314PubMedCrossRefGoogle Scholar
  70. 70.
    Mullen DL, Silverberg SG, Penn I, Hammond WS (1976) Squamous cell carcinoma of the skin and lip in renal homograft recipients. Cancer 37:729–734PubMedCrossRefGoogle Scholar
  71. 71.
    Nagel GA, Arneault GS, Holland IF, Kirkpatrick D, Kirkpatrick R (1970) Cell-mediated immunity against malignant melanoma in monozygous twins. Cancer Res 30:1828–1832PubMedGoogle Scholar
  72. 72.
    Ninger E, Zemanova D, Kovarik I, Lauerova L (1979) Evaluation of the E-rosette assay in melanoma patients. Cancer Immunol Immunother 6:121–124CrossRefGoogle Scholar
  73. 73.
    Noack M, Bloedhorn H, Herrmann WP (1979) Lymphocyte response to mitogens in patients with malignant melanoma. Arch Dermatol Res 264:351–355PubMedCrossRefGoogle Scholar
  74. 74.
    Nordquist BC, Kinney (1976) T and B cells and cell-mediated immunity in mycosis fungoides. Cancer 37:714–718CrossRefGoogle Scholar
  75. 75.
    Penn I, Starzl TE (1972) Malignant tumors arising de novo in immunosuppressed organ transplant recipients. Transplantation 14:407–417PubMedCrossRefGoogle Scholar
  76. 76.
    Pritchard DI, Ritts RE, Taylor WF, Miller GC (1978) A prospective study of immune responsiveness in human melanoma. Cancer 41:2165–2173PubMedCrossRefGoogle Scholar
  77. 77.
    Rajka G (1968) Delayed dermal and epidermal reactivity in atopic dermatitis (prurigo Besnier). Acta Derm Venereol (Stockh): 48:186–191Google Scholar
  78. 78.
    Rajka G, Barlinn C (1979) On the significance of the trichophytin reactivity in atopic dermatitis. Acta Derm Venereol (Stockh) 59:45–47Google Scholar
  79. 79.
    Robinowitz BN, Noguchi S, Roenigk HH (1976) Tumor cell characterization in mycosis fungoides. Cancer 37:1747–1753PubMedCrossRefGoogle Scholar
  80. 80.
    Roses DF, Campion IF, Harris MN, Gumport SL (1979) Maügnant melanoma. Delayed hyper-sensitivity skin testing. Arch Surg 114:35–38PubMedGoogle Scholar
  81. 81.
    Sauder DN, Bailin PL, Sundeen J, Krakauer. RS (1980) Suppressor cell function in psoriasis. Arch Dermatol 116:51–55CrossRefGoogle Scholar
  82. 82.
    Schöpf E, Böhringer D (1974) IgE and cell-mediated immunity in atopic dermatitis. J Dermatol (Tokyo) 1:133–144Google Scholar
  83. 83.
    Schuppli R (1976) Is mycosis fungoides an “immunoma”? Dermatologica 153:1–6PubMedCrossRefGoogle Scholar
  84. 84.
    Schuster DL, Pierson D, Bongiovanni B, Levinson AI (1979) Suppressor cell function in atopic dermatitis associated with elevated immunoglobulin E. J Allergy Clin Immunol 64:139–145CrossRefGoogle Scholar
  85. 85.
    Seigier HF, Shingleton WW, Metzgar RS, Buckley CE, Bergoc PM, Miller DS, Fetter BF, Phaup MB (1972) Non-specific and specific immunotherapy in patients with melanoma. Surgery 72:162–174Google Scholar
  86. 86.
    Silverman NA, Alexander IC, Potvin C, Chretien PB (1976) In vitro lymphocyte reactivity and T-cell levels in patients with melanoma: Correlations with clinical and pathological stage. Surgery 79:332–339PubMedGoogle Scholar
  87. 87.
    Spitler LE, Littooy FN, Sagebiel RW (1977) Cellular immunity in patients with malignant melanoma and their household contacts. Cancer Immunol Immunother 2:69–76CrossRefGoogle Scholar
  88. 88.
    Tan RS-H, Butterworth CM, McLaughlin H, Malka S, Samman PD (1974) Mycosis fungoides — a disease of antigen persistence. Br J Dermatol 91:607–616PubMedCrossRefGoogle Scholar
  89. 89.
    Thatcher N, Palmer MK, Gasiunas N, Crowther D (1977) Lymphocyte function and response to chemoimmunotherapy in patients with metastatic melanoma. Br J Cancer 36:751–762PubMedCrossRefGoogle Scholar
  90. 90.
    Theml H (1978) Die chronische lymphatische Leukämie. In: Begemann H (ed) Handbuch der inneren Medizin, vol 2/6. (Hrsg) Springer, Berlin Heidelberg New York, pp 519–619Google Scholar
  91. 91.
    Tirelli U. Veronesi A, Galligioni E, Trovo MG, Magri D, Frustaci S, Crivellavi D, Roncadin M, Tumolo S, Grigoletto E (1979) Clinical and immunological evaluation of 5 cases of mycosis fungoides in advanced stages. Tumori 65:447–453PubMedGoogle Scholar
  92. 92.
    Trepel F (1974) Number and distribution of lymphocytes in man. A critical analysis. Klin Wochenschr 52:511PubMedCrossRefGoogle Scholar
  93. 93.
    Tritsch H (1970) Dermale Reaktionen auf Melanom-Autohomogenate. Hautarzt 21:258–265PubMedGoogle Scholar
  94. 94.
    Van der Harst-Oostveen CIGR, van Vloten WA (1978) Delayed-type hypersensitivity in patients with mycosis fungoides. Dermatologica 157:129–135PubMedCrossRefGoogle Scholar
  95. 95.
    Wahba A, Cohen H, Bar-Eli M, Callily R (1979) Neutrophil Chemotaxis in psoriasis. Acta Derm Venereol (Stockh) 59:441–445Google Scholar
  96. 96.
    Wassermann I, Biberfeld G, Baral E, Blomgren H, Thyresson N, Bremer-Anderssen E (1980) Suppressor T cells in mycosis fungoides and so-called premycotic eruption. Acta Derm Venereol (Stockh) 60:139–143Google Scholar
  97. 97.
    Weesbach HW, Lischka G, Tritsch H (1972) Fähigkeit zur Spätreaktion bei Patienten mit malignem Melanom. Arch Dermatol Res 245:346–352Google Scholar
  98. 98.
    Westburg SP, Stone OI (1973) Multiple cutaneous squamous cell carcinomas during immunosuppressive therapy. Arch Dermatol 107:893–895PubMedCrossRefGoogle Scholar
  99. 99.
    Winkelmann RK (1974) Clinical studies of T-cell erythroderma in the Sezary syndrome. Mayo Clin Proc 49:519–525PubMedGoogle Scholar
  100. 100.
    Worman CP, Burns GF, Barker CR (1978) Evidence for the presence of a receptor for IgM on the pathological cells of Sezary’s syndrome. Clin Exp Immunol 31:391–396PubMedGoogle Scholar
  101. 101.
    Zachariae H, Ellegaard I, Grunnet E, Sogaard H, Thulin H (1975 T and B cells and IgE in mycosis fungoides. Acta Derm Venereol (Stockh) 55:466–468Google Scholar
  102. 102.
    Zachariae H, Grunnet E, Thestrup-Pedersen K (1979) Transfer factor in mycosis fungoides: A case report on a patient “cured”. Acta Derm Venereol (Stockh) 59:375–378Google Scholar
  103. 103.
    Ziegler JL, Lewis MG, Luyombya JMS, Kiryabwire JWM (1969) Immunologic studies in patients with malignant melanoma in Uganda. Br J Cancer 23:729–734PubMedCrossRefGoogle Scholar
  104. 104.
    Zirbs W (1981) Immunitätslage beim malignen Melanom. Medical dissertation, University of MunichGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1981

Authors and Affiliations

  • G. Burg
    • 1
  • T. Rehle
    • 1
  1. 1.Dermatologische Klinik und PoliklinikLudwig-Maximilians-UniversitätMünchenGermany

Personalised recommendations